Treatment of dry age‐related macular degeneration: A review
Clinical & Experimental Ophthalmology · 2023-11 · 51 (8) · 835-852
DOI: 10.1111/ceo.14294 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 22.09.2023. Verfasst von Shenouda Girgis und 1 weiteren Autor:innen. Beteiligte Einrichtung: City Eye Centre, Brisbane, Australia. Hauptthemen laut MEDLINE: Geographic Atrophy, Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Age‐related macular degeneration is a global disease with a significant societal impact. The advent of anti‐vascular endothelial growth factor therapy (anti‐VEGF) has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD). Dry age‐related macular degeneration (dAMD) is being investigated for possible therapeutic options. The therapeutic categories undergoing clinical trials include complement pathway inhibitors, visual cycle modulators, reduction of toxic byproducts, antioxidative therapy, neuroprotective agents, laser therapy, surgical options, gene therapy, stem cell therapy, and miscellaneous treatments. Two intravitreal anti‐complement factors (pegcetacoplan and avacincaptad pegol) have recently shown phase 3 clinical trial evidence of a reduction in the growth of geographic atrophy. In this review, we provide an update on treatment options currently undergoing clinical research trials for the management of dAMD and preventing the progression of Geographic Atrophy (GA).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- City Eye Centre, Brisbane, Australia.
- Royal Brisbane and Women's Hospital, Brisbane, Australia.
- Faculty of Medicine, University of Queensland, Saint Lucia, Queensland, Australia.
ORCID-Profile: Shenouda Girgis
Zitieren
APA
Girgis, S., & Lee, L. R. (2023). Treatment of dry age‐related macular degeneration: A review. Clinical & Experimental Ophthalmology, 51(8), 835-852. https://doi.org/10.1111/ceo.14294
Vancouver
Girgis S, Lee LR. Treatment of dry age‐related macular degeneration: A review. Clinical & Experimental Ophthalmology. 2023;51(8):835-852. doi:10.1111/ceo.14294
BibTeX
@article{Girgis2023,
author = {Girgis, Shenouda and Lee, Lawrence R},
title = {Treatment of dry age‐related macular degeneration: A review},
journal = {Clinical & Experimental Ophthalmology},
year = {2023},
volume = {51},
number = {8},
pages = {835--852},
doi = {10.1111/ceo.14294}
}
EUVIMED